Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
imported>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|has_document=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|RefScope=HM
|module=1
|RefDocPart=Glossary - clinical trial
|unit=1.2.1
|RefLanguage=EN
|scope=HM
|RefTags=TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud
|doc_part=Glossary - clinical trial
|RefModule=1
|language=EN
|RefUnit=1.2.1
|entry_by=Florian Adragna
}}
|contributors=
 
|tags=TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud
{{:Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995}}
|tags_display=[[Glossary:TAG-00008-Cli-ngK|Clinical trial]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00011-Inv-tud|Investigational drug (IMP)]]
 
|comment=Definition of clinical trial (systematic study on pharmaceutical products)
{| class="wikitable gplx-infobox"
|content=clinical trial
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 1 — Unit 1.2.1
|-
! Scope
| HM
|-
! Document part
| Glossary - clinical trial
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00008-Cli-ngK|Clinical trial]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00011-Inv-tud|Investigational drug (IMP)]]
|-
! Comment
| Definition of clinical trial (systematic study on pharmaceutical products)
|}
 
== Content ==
clinical trial
A systematic study on pharmaceutical products in human subjects (including patients and other volunteers) in order to discover or verify the effects of and/or identify any adverse reaction to investigational products, and/or to study the absorption, distribution, metabolism and excretion of the products with the object of ascertaining their efficacy and safety.  
A systematic study on pharmaceutical products in human subjects (including patients and other volunteers) in order to discover or verify the effects of and/or identify any adverse reaction to investigational products, and/or to study the absorption, distribution, metabolism and excretion of the products with the object of ascertaining their efficacy and safety.  
[...]
[...]
}}

Latest revision as of 13:49, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.2.1
Scope HM
Document part Glossary - clinical trial
Language EN
Original entry by Florian Adragna
Contributors
Tags Clinical trial, Definition, Investigational drug (IMP)

Content

clinical trial A systematic study on pharmaceutical products in human subjects (including patients and other volunteers) in order to discover or verify the effects of and/or identify any adverse reaction to investigational products, and/or to study the absorption, distribution, metabolism and excretion of the products with the object of ascertaining their efficacy and safety. [...]

Retrieved from "https://gxplex.org/index.php?title=Reference:WHO_WHO_-_Guidelines_for_GCP_for_trials_on_pharmaceutical_products*_1995_Glossary_-_clinical_trial&oldid=17265"